AI is reshaping the life sciences industry in ways that are no longer hypothetical. The question is no longer whether to ...

AI's ability to monitor a warfighter’s mental state, visuals or inner dialog may outpace the ability to shield that data from ...

The life sciences and healthcare industries have remained a major focus for government enforcers in the Trump administration.

PEEK variants offer better heat resistance and processing flexibility while new rules govern pellet handling across ...

The Expert Consumers review positions Forme as a notable example of how ergonomic posture wear is evolving to meet modern ...

Executed in accordance with FDA human factors and usability engineering guidance, the study is intended to de-risk downstream regulatory review ...

A larger trial of trigeminal nerve stimulation in children with ADHD produce results that differ from an earlier pilot study, raising new questions about its efficacy.

The Indomo ClearPen is yet to be approved in the UK, but the founders hope for future availability ...

Their dividend streaks speak volumes.

Abbott Laboratories (NYSE:ABT) detailed fourth-quarter 2025 results and outlined its 2026 outlook on its earnings conference call, emphasizing continued momentum in medical devices, a transition plan ...

AI-powered medical wearables and software are flourishing following the FDA’s new hands-off regulatory guidance.

U.S. Food and Drug Administration (FDA) updated the final guidance documents General Wellness: Policy for Low Risk Devices (the General Wellness Guidance) and ...